Literature DB >> 344223

Adult mice as a model for early onset group B streptococcal disease.

D E Wennerstrom, R W Schutt.   

Abstract

The intravenous inoculation of adult mice with virulent group B streptococci serotype Ia resulted in fulminating sepsis with extensive colonization of the lungs and kidneys. The time course of the infection lasting 24 to 40 h, extensive pulmonary colonization, and resistance of the type Ia organism to phagocytosis in the absence of specific antibody suggest that mice are an appropriate model for the study of early onset streptococcal infection of human neonates.

Entities:  

Mesh:

Year:  1978        PMID: 344223      PMCID: PMC414142          DOI: 10.1128/iai.19.2.741-744.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  Group B streptococcal neonatal and infant infections.

Authors:  R A Franciosi; J D Knostman; R A Zimmerman
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

2.  A comparison of early-onset group B steptococcal neonatal infection and the respiratory-distress syndrome of the newborn.

Authors:  R C Ablow; S G Driscoll; E L Effmann; I Gross; C J Jolles; R Uauy; J B Warshaw
Journal:  N Engl J Med       Date:  1976-01-08       Impact factor: 91.245

3.  Cellular and humoral immune response to group B streptococci.

Authors:  P H Klesius; R A Zimmerman; J H Mathews; D H Krushak
Journal:  J Pediatr       Date:  1973-12       Impact factor: 4.406

4.  Opsonin system of the group B streptococcus.

Authors:  J H Mathews; P H Klesius; R A Zimmerman
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

5.  Pulmonary changes in neonatal sepsis to group B beta-hemolytic Streptococcus: relation of hyaline membrane disease.

Authors:  A L Katzenstein; C Davis; A Braude
Journal:  J Infect Dis       Date:  1976-04       Impact factor: 5.226

6.  The effect of two isomeric octadecenoic acids on the lipid metabolism and growth of Novikoff hepatoma cells.

Authors:  D E Wennerstrom; H M Jenkin
Journal:  Biochim Biophys Acta       Date:  1976-06-22

7.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

  7 in total
  17 in total

1.  Nonopsonic binding of type III Group B Streptococci to human neutrophils induces interleukin-8 release mediated by the p38 mitogen-activated protein kinase pathway.

Authors:  E A Albanyan; J G Vallejo; C W Smith; M S Edwards
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Group B streptococcal type Ia sepsis in mice after intranasal inoculation and the effect of infection on lungs.

Authors:  D E Wennerstrom
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

3.  Possible virulence marker for Streptococcus agalactiae (Lancefield Group B).

Authors:  G Orefici; S Recchia; L Galante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

4.  Lethal synergism induced in mice by influenza type A virus and type Ia group B streptococci.

Authors:  W T Jones; J H Menna; D E Wennerstrom
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

5.  Bactericidal capacity of newborn phagocytes against group B beta-hemolytic streptococci.

Authors:  I D Becker; O M Robinson; T S Bazán; M López-Osuna; R R Kretschmer
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

6.  Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis.

Authors:  L Tissi; P Marconi; P Mosci; L Merletti; P Cornacchione; E Rosati; S Recchia; C von Hunolstein; G Orefici
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

7.  Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice.

Authors:  Qi Cheng; Steven Debol; Hong Lam; Ron Eby; Lorri Edwards; Yury Matsuka; Stephen B Olmsted; P Patrick Cleary
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

8.  Opsonin-independent phagocytosis of group B streptococci: role of complement receptor type three.

Authors:  J M Antal; J V Cunningham; K J Goodrum
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Mouse protection assay for group B streptococcus type III.

Authors:  D O Fleming
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

10.  Mucin model for group B type III streptococcal infection in mice.

Authors:  D O Fleming
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.